FLT3 Mutations in Acute Myeloid Leukemia
The prevalence of an internal tandem duplication (ITD) of the juxtamembrane domain-coding sequence and a missense mutation of D835 within the kinase domain of the FLT3 gene is 15–35% and 5–10% of adults with acute myeloid leukemia (AML), respectively. In addition, point mutations, deletions, and insertions have been found in the juxtamembrane domain and in the other codons within the kinase domain, though these are less common. Several large-scale studies in well-documented patients published to date have demonstrated that FLT3 mutations are strongly associated with a poor prognosis and a high leukemia cell count in patients with AML, suggesting that FLT3 mutations are involved in disease progression. Because the detection of FLT3 mutations is fast, easy, and inexpensive, mutation analysis should be performed as a routine test. This chapter describes methods for detecting ITD and D835 mutations in the FLT3 gene.
- Reciprocal Subtraction Differential RNA Display (RSDD): An Efficient Technology for Cloning Differentially Expressed Genes
- TNF in Experimental Diseases of the CNS
- High-Throughput Mutation Screening Using a Single Amplification Condition
- Design and Testing of Novel Oncolytic Vaccinia Strains
- Suppression Subtractive Hybridization for Identification and Functional Analysis of Tumor Suppressor Genes
- Green Fluorescent Protein for Metastasis Research
- 7 In Vitro Methods for Evaluation of P450-Based Anticancer Gene Therapy
- In Vitro Invasion Assay Using Matrigel: A Reconstituted Basement Membrane Preparation
- Assessment of Gelatinases (MMP-2 and MMP-9) by Gelatin Zymography
- Gold Nanorods: Multifunctional Agents for Cancer Imaging and Therapy